Changes in serum concentrations of C-reactive protein and soluble adhesion molecules sE-selectin and sICAM-1 after transdermal substitution by 17-β-estradiol;Změny sérové koncentrace C-reaktivního proteinu a solubilních adhezivních molekul sE-selektinu a sICAM-1 po transdermální substituci 17-β estradiolem

Ceska Gynekologie

Volumn 66, Issue 3, 2001, Pages 161-165

  Kvasnicka J Jr ^a   Zivny J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

C reactive protein; E selectin; Estradiol; ICAM 1

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; ESTROGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN THERAPY; FEMALE; HUMAN; HYSTERECTOMY; PROTEIN BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; ADNEXA UTERI; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; E-SELECTIN; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYSTERECTOMY; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; RISK FACTORS;

EID: 0010825871     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors
2. The acute phase response
3. Menopause and the risk of coronary heart disease in women
4. Biological effects of estradiol-17 beta in postmenopausal women: Oral versus percutaneous administration
5. Estriol sensitizes rat Kupffer cells via gut-derived endotoxin
6. Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women
7. Mechanisms of disease: Acute - Phase proteins and other systemic responses to inflammation
8. Long-term influence of different postmenopausal hormone replacement regiments on serum lipids and lipoprotein (a): A randomised study
9. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives
10. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
11. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study
12. Estrogen increase sensitivity of hepatic Kupffer cells to endotoxin
13. Elevated levels of sE-selectin in post-menopausal females are decreased by hormone replacement therapy to levels observed in pre-menopausal females
14. Estrogen replacement therapy and coagulation: Relationship to lipid and lipoprotein changes
15. Endoteliální buňky a leukocyty - Význam adhezivních interakcí
16. The effect of transdermal oestradiol and oral progestogens on haemostasis variables
17. Změny hladiny cytoadhesivních molekul, proteinů akutní fáze, lipidů a hemostázy ve vztahu k hladině endogenních estrogenů v těhotenství a po ovarektomii
18. Patterns of coronary disease morbidity and mortality: A 26-year follow-up of the Framingham population
19. Cytokine regulation of endothelial cell function: From molecular level to the bedside
20. The protective effect of estrogen on the cardiovascular system
21. Antioxidant and prooxidant actions of estrogens: Potential physiological and clinical implications
22. Hepatobiliary excretion of cysteinyl leukotrienes in three experimental models of acute hepatic injury
23. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
24. Hormone replacement therapy and increased plasma concentration of C-reactive protein
25. The pathogenesis of atherosclerosis: A perspective for the 1990s
26. Mechanisms of disease: Atherosclerosis - An inflammatory disease
27. Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2-diabetes
28. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women - A randomized controlled trial
29. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism
30. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
31. Optimising delivery systems for HRT
32. Estrogen inhibits phorbol-ester induced I kappa B alpha transcription and protein degradation
33. The menopause and hormone replacement therapy: Lipids, lipoproteins, coagulation and fibrinolytic factors
34. Hormonal regulation of lipoprotein(a) levels: Effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopauseal women
35. Quantitative determination of C-reactive protein using the microturbidimetry method
36. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
37. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial